MMPS, TIMP-2, and TGF-β1 in the cancerization of oral lichen planus

被引:53
作者
Chen, Yu [2 ]
Zhang, Weiping [1 ]
Geng, Ning [2 ]
Tian, Kun [3 ]
Windsor, Lester Jack [1 ]
机构
[1] Indiana Univ, Sch Dent, Dept Oral Biol, Indianapolis, IN 46204 USA
[2] Sichuan Univ, W China Coll Stomatol, Dept Oral Pathol, Chengdu 610064, Peoples R China
[3] Sichuan Univ, W China Coll Stomatol, Dept Prosthodont, Chengdu 610064, Peoples R China
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2008年 / 30卷 / 09期
关键词
matrix metalloproteinases; transforming growth factor-beta 1; tissue inhibitor of matrix metalloproteinases; oral lichen planus; squamous cell carcinoma;
D O I
10.1002/hed.20869
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. Matrix metalloproteinases (MMPs) and transforming growth factor-pi (TGF-beta 1) are important in many physiological and pathological processes. Methods. Immunohistochemistry for MMP-2, MMP-9, membrane-type 1 MMP (MT1-MMP, MMP-14), tissue inhibitor of matrix metalloproteinase (TIMP)-2, and TGF-beta were performed on normal mucosa, nonatrophic oral lichen planus, atrophic oral lichen planus, and oral squamous cell carcinomas (OSCC) resulting from lichen planus. Results. Expression of MMPs progressively increased from normal mucosa to nonatrophic oral lichen planus, atrophic oral lichen planus, and OSCCs. Immunoscores of MMPs in atrophic oral lichen planus was significantly greater than nonatrophic oral lichen planus. Moreover, immunoscore of MMP-9 of OSCCs was significantly greater than both atrophic and nonatrophic lichen planus. Furthermore, expression of TIMP-2 and TGF-beta 1 paralleled increases seen with MMPs. Conclusions. Imbalance between MMPs and TIMPs may be involved in cancerization of oral lichen planus. MMP-2, MT1-MMP, and especially MMP-9 may be useful markers for judging potency of malignant transformation from oral lichen planus. (c) 2008 Wiley Periodicals, Inc.
引用
收藏
页码:1237 / 1245
页数:9
相关论文
共 38 条
  • [1] High expression levels of nuclear factor kappa B and gelatinases in the tumorigenesis of oral squamous cell carcinoma
    Bindhu, O. S.
    Ramadas, K.
    Sebastian, Paul
    Pillai, M. Radhakrishna
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2006, 28 (10): : 916 - 925
  • [2] Bode W, 2003, BIOCHEM SOC SYMP, V70, P1
  • [3] [蔡华雄 Cai Huaxiong], 2002, [中山医科大学学报, Academic Journal of Sun Yat-sen University of Medical Sciences], V23, P477
  • [4] CAWSON RA, 2002, DIS ORAL MUCOSA NONI, P197
  • [5] What is transforming growth factor-beta (TGF-β)?
    Chin, D
    Boyle, GM
    Parsons, PG
    Coman, WB
    [J]. BRITISH JOURNAL OF PLASTIC SURGERY, 2004, 57 (03): : 215 - 221
  • [6] Cancer therapy - Matrix metalloproteinase inhibitors and cancer: Trials and tribulations
    Coussens, LM
    Fingleton, B
    Matrisian, LM
    [J]. SCIENCE, 2002, 295 (5564) : 2387 - 2392
  • [7] Immune enhancement of skin carcinogenesis by CD4+T cells
    Daniel, D
    Meyer-Morse, N
    Bergsland, EK
    Dehne, K
    Coussens, LM
    Hanahan, D
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (08) : 1017 - 1028
  • [8] Dissemond Joachim, 2004, J Dermatolog Treat, V15, P136, DOI 10.1080/09546630410030720
  • [9] Role of transforming growth factor beta in human cancer
    Elliott, RL
    Blobe, GC
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (09) : 2078 - 2093
  • [10] Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck - Correlation with p53 status, inducible nitric oxide synthase activity, and anigogenesis
    Franchi, A
    Santucci, M
    Masini, E
    Sardi, I
    Paglierani, M
    Gallo, O
    [J]. CANCER, 2002, 95 (09) : 1902 - 1910